{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:42Z","timestamp":1786991202843,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.jacc.2003.11.028","type":"journal-article","created":{"date-parts":[[2004,3,12]],"date-time":"2004-03-12T05:20:40Z","timestamp":1079068840000},"page":"929-935","source":"Crossref","is-referenced-by-count":87,"title":["Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation"],"prefix":"10.1016","volume":"43","author":[{"given":"Stanley G","family":"Rockson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2003.11.028_BIB1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.51.3.674","article-title":"Prevention of stroke in patients with nonvalvular atrial fibrillation","volume":"51","author":"Hart","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2003.11.028_BIB2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB4","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2003.11.028_BIB5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2003.11.028_BIB6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-131-9-199911020-00010","article-title":"Atrial fibrillation and thromboembolism","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0140-6736(98)09233-2","article-title":"New antithrombotic agents","volume":"353","author":"Hirsh","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2003.11.028_BIB8","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1378\/chest.119.1_suppl.22S","article-title":"Managing oral anticoagulant therapy","volume":"119","author":"Ansell","year":"2001","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2003.11.028_BIB9","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1378\/chest.119.1_suppl.194S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2003.11.028_BIB10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0735-1097(01)01587-X","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation","volume":"38","author":"Fuster","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2003.11.028_BIB11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1052-3057(10)80166-1","article-title":"Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation","volume":"5","year":"1995","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2003.11.028_BIB12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2003.11.028_BIB13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.CIR.102.1.11","article-title":"Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation","volume":"102","author":"Go","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.11.028_BIB14","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2003.11.028_BIB15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.163.8.936","article-title":"A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin","volume":"163","author":"Van Walraven","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB16","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.11.028_BIB17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2003.11.028_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-0690(05)70102-6","article-title":"Oral anticoagulants","volume":"17","author":"Hylek","year":"2001","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.STR.26.8.1471","article-title":"Oral anticoagulants and intracranial hemorrhage","volume":"26","author":"Hart","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2003.11.028_BIB20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2165\/00003088-199630060-00002","article-title":"Clinically important drug interactions with anticoagulants","volume":"30","author":"Harder","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2003.11.028_BIB21","unstructured":"Warfarin. RxList LLC. Available at: www.rxlist.com. Accessed February 13, 2003."},{"key":"10.1016\/j.jacc.2003.11.028_BIB22","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB23","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB24","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.11.028_BIB25","unstructured":"Halperin J, Nevinson M. Stroke prevention using oral direct thrombin inhibitor, ximelagatran, compared with warfarin in patients with nonvascular atrial fibrillation: the SPORTIF III trial. Lancet 2004. In Press."}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704000117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704000117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T13:23:54Z","timestamp":1550150634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109704000117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0735109704000117"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2003.11.028","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}